Related Experiment Video

Updated: Jun 9, 2026

MicroRNA Detection in Prostate Tumors by Quantitative Real-time PCR (qPCR)
08:30

MicroRNA Detection in Prostate Tumors by Quantitative Real-time PCR (qPCR)

Published on: May 16, 2012

miR-148a is an androgen-responsive microRNA that promotes LNCaP prostate cell growth by repressing its target CAND1

T Murata1, K Takayama, S Katayama

  • 1Department of Anti-Aging Medicine, University of Tokyo, Bunkyo-ku, Tokyo, Japan.

Prostate Cancer and Prostatic Diseases
|September 8, 2010
PubMed

Insights

MicroRNAs (miRNAs) regulate cancer genes. This study found that miR-148a promotes prostate cancer cell growth by reducing CAND1 expression, suggesting its role in human prostate cancer progression.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • MicroRNAs (miRNAs) are key regulators in cancer biology, acting as tumor suppressors or oncogenes.
  • The androgen-dependent gene network significantly influences prostate cancer growth, but the role of miRNAs is not fully understood.

Purpose of the Study:

  • To identify androgen-responsive miRNAs in prostate cancer.
  • To investigate the function of specific miRNAs in prostate cancer cell proliferation.

Main Methods:

  • Short RNA sequencing was employed to identify androgen-responsive miRNAs in LNCaP prostate cancer cells.
  • The regulatory relationship between miR-148a and cullin-associated and neddylation-dissociated 1 (CAND1) was analyzed.
  • Small interfering RNA (siRNA) was used to knock down CAND1 expression.

Main Results:

  • miR-148a was identified as an androgen-responsive miRNA in prostate cancer cells.
  • miR-148a directly targets the 3'-untranslated region of CAND1 mRNA, leading to reduced CAND1 expression.
  • Knockdown of CAND1 using siRNA significantly promoted LNCaP cell proliferation.

Conclusions:

  • miR-148a plays a role in regulating CAND1, a component of ubiquitin ligase complexes.
  • The findings suggest that miR-148a contributes to the proliferation of human prostate cancer cells, highlighting its potential as a therapeutic target.

More Related Videos

miRNA Expression Analyses in Prostate Cancer Clinical Tissues11:29

miRNA Expression Analyses in Prostate Cancer Clinical Tissues

Published on: September 8, 2015

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA (lncRNA)...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...